期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | American Journal of Translational Research LetPub Score 5.1
50 ratings
Rate
Reputation 3.7 Influence 5.4 Speed 8.9 | ||||||||||||||||||||||||
期刊簡稱 | AM J TRANSL RES | ||||||||||||||||||||||||
ISSN | 1943-8141 | ||||||||||||||||||||||||
h-index | 45 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 5.90%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://www.ajtr.org/ | ||||||||||||||||||||||||
在線稿件提交 | http://www.e-century.us/submission/app.php?j=ajtr | ||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||
出版商 | e-Century Publishing Corporation | ||||||||||||||||||||||||
主題領域 | ONCOLOGY | ||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||
發行頻率 | |||||||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||||||
每年文章數 | 661每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 0.07% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1943-8141%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[American Journal of Translational Research] 的評論 | 撰寫評論 |
作者: A-宁静致远 領域: 医学 審稿時間: 2.0 month(s) 結果: 直接被接受 撰寫評論 |
2024-03-30 15:02:33 評論於 This magazine has published many articles. If interested, please direct message for fast response(1) 讚! | A-宁静致远 |
作者: 45度沉默 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-03-29 18:01:44 評論於 Please translate the following paragraph into English and Japanese, and title them respectively as ":" and ":"(0) 讚! | 45度沉默 |
作者: Rocky2022 領域: 医学 審稿時間: 1.0 month(s) 結果: 直接被接受 撰寫評論 |
2024-03-28 20:36:57 評論於 If you need assistance, you can send a private message(0) 讚! | Rocky2022 |
作者: 极乐骏奇 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-18 08:39:30 評論於 Please help me(0) 讚! | 极乐骏奇 |
作者: 极乐骏奇 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-25 11:42:04 評論於 Emphasis on research direction: Oncology; Tumor; Experience sharing in bioinformatics analysis: This journal is no longer a warning journal, time flies(0) 讚! | 极乐骏奇 |
作者: 邻家奇玮 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-27 18:26:26 評論於 Can we talk privately now?(0) 讚! | 邻家奇玮 |
作者: 葵花德运 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-23 17:16:30 評論於 This unexpectedly doesn't have a DOI, feels unreliable(0) 讚! | 葵花德运 |
作者: Archer Anna 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-28 09:05:50 評論於 Review Speed: 6.0 | Submission Acceptance Rate: 75.0 Research Focus: Tumor Experience: It took quite a while, about 5 months. The downside is that the impact factor at acceptance was 3.9, but it dropped to 2.2 in less than a month. However, one must learn to be content. Being accepted is what matters. The article itself didn't require too much effort, as the reviewers and editor didn't have many difficult suggestions, mostly related to formatting issues(0) 讚! | Archer Anna |
作者: Ivan Adams 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-25 12:09:22 評論於 Hello, I would like to ask if this alert is still divided into special issue and regular issue? It seems like there are more special issue alerts. Can I still submit?(0) 讚! | Ivan Adams |
作者: 终幕语薇 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-18 18:00:01 評論於 Review speed: 1.0 | Submission hit rate: 50.0 Emphasized research direction: oncology; sharing of oncology experiences: journals still require, ethics, polishing, there are many opinions for revision, fortunately accepted(0) 讚! | 终幕语薇 |
作者: 韦陀飞虎 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-05 19:57:31 評論於 The manuscript has been withdrawn and a warning has been issued(0) 讚! | 韦陀飞虎 |
作者: Archer Anna 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-03 19:19:51 評論於 I'm a bit confused. I haven't received any emails about revisions(0) 讚! | Archer Anna |
作者: Archer Anna 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-03 16:50:15 評論於 The data for the past 22 years has been disclosed, so please check it yourself and don't mislead others(0) 讚! | Archer Anna |
作者: Archer Anna 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-03 13:28:36 評論於 Brother, yours is in real-time, it will be announced in half a year(0) 讚! | Archer Anna |
作者: 无妄雪柳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-10 18:15:27 評論於 You are looking at the real-time impact factor, but I see the estimated factor is still around 3.7(0) 讚! | 无妄雪柳 |
作者: 慈悲珺琦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-07 11:05:52 評論於 If 4.06→3.94→1.955, I have never seen such a provocative magazine(0) 讚! | 慈悲珺琦 |
作者: 慈悲珺琦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-06 23:05:08 評論於 Editorial speed: 2.0 | Submission acceptance rate: 95.0 Focused research areas: Oncology; Experience sharing in bioinformatics analysis: It's better not to submit in 2023, with the impact factor of 4.06 in 2020, 3.94 in 2021, and 1.96 in 2022. I've never seen such a tricky journal. Oncology Letters and Oncology Reports are better(0) 讚! | 慈悲珺琦 |
作者: 无妄雪柳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-30 12:52:27 評論於 Not yet, but it will be updated soon(0) 讚! | 无妄雪柳 |
作者: 北斗珉瑶 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-27 17:42:10 評論於 How can I contact you?(0) 讚! | 北斗珉瑶 |
作者: 是你的康复呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-24 16:20:17 評論於 Hello, is this high-risk, or is it in the risk journal?(0) 讚! | 是你的康复呀 |
作者: 无妄雪柳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-19 23:39:42 評論於 The school's newsletter will be available by the end of the month(0) 讚! | 无妄雪柳 |
作者: 无妄雪柳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-19 12:31:17 評論於 I just received it too, there was no reminder before, and I only found out later that this journal does not have a DOI, and it's basically all Chinese, which makes it too easy to tip off(0) 讚! | 无妄雪柳 |
作者: 一只成荫呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-18 21:53:02 評論於 Where can I see the latest warning periodicals?(0) 讚! | 一只成荫呀 |
作者: 北斗珉瑶 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-18 20:56:37 評論於 Really? Is this a scam? Don't scare me(0) 讚! | 北斗珉瑶 |
作者: 无妄雪柳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-07 10:43:42 評論於 For those who are still submitting, I suggest withdrawing your submission. I have already seen the latest alert journal, which is a high-risk journal. It will be published at the end of the month, so be cautious about submitting(0) 讚! | 无妄雪柳 |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us